A5010822882- COVID-19 epidemiological studies
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Vaccine Coverage and Hesitancy
- Geriatric Care and Nursing Homes
- COVID-19 and Mental Health
- Toxin Mechanisms and Immunotoxins
- Biosensors and Analytical Detection
- Silkworms and Sericulture Research
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Celiac Disease Research and Management
- Neonatal Respiratory Health Research
Public Health Agency of Canada
2021-2022
York University
2020-2021
Two of the Coronavirus Disease 2019 (COVID-19) vaccines currently approved in United States require 2 doses, administered 3 to 4 weeks apart. Constraints vaccine supply and distribution capacity, together with a deadly wave COVID-19 from November 2020 January 2021 emergence highly contagious Severe Acute Respiratory Syndrome (SARS-CoV-2) variants, sparked policy debate on whether vaccinate more individuals first dose available delay second or continue recommended 2-dose series as tested...
The COVID-19 pandemic has stimulated wastewater-based surveillance, allowing public health to track the epidemic by monitoring concentration of genetic fingerprints SARS-CoV-2 shed in wastewater infected individuals. Wastewater-based surveillance for is still its infancy. In particular, quantitative link between clinical cases observed through traditional and signals from viral concentrations developing hampers interpretation data actionable public-health decisions. We present a modelling...
The novel coronavirus disease 2019 (COVID-19) has caused severe outbreaks in Canadian long-term care facilities (LTCFs). In Canada, over 80% of COVID-19 deaths during the first pandemic wave occurred LTCFs. We sought to evaluate effect mitigation measures LTCFs including frequent testing staff, and vaccination staff residents. developed an agent-based transmission model parameterized it with disease-specific estimates, temporal sensitivity nasopharyngeal saliva testing, results vaccine...
Abstract Two of the COVID-19 vaccines currently approved in United States require two doses, administered three to four weeks apart. Constraints vaccine supply and distribution capacity, together with a deadly wave from November 2020 January 2021 emergence highly contagious SARS-CoV-2 variants, sparked policy debate on whether vaccinate more individuals first dose available delay second dose, or continue recommended two-dose series as tested clinical trials. We developed an agent-based model...
Despite passive immunization with palivizumab to select high-risk children under two years of age, the health and economic burden respiratory syncytial virus (RSV) remains substantial. We evaluated effectiveness cost-effectiveness programs new generations RSV prophylactics, including long-acting monoclonal antibodies (LAMA) maternal vaccines, in terms reducing hospitalizations Nunavik, a Canadian Arctic region.
The novel coronavirus disease 2019 (COVID-19) has caused severe outbreaks in Canadian long-term care facilities (LTCFs). In Canada, over 80% of COVID-19 deaths during the first pandemic wave occurred LTCFs. We sought to evaluate effect mitigation measures LTCFs including frequent testing staff, and vaccination staff residents. developed an agent-based transmission model parameterized it with disease-specific estimates, temporal sensitivity nasopharyngeal saliva testing, results vaccine...
1 Abstract The COVID-19 pandemic has stimulated wastewater-based surveillance, allowing public health to track the epidemic by monitoring concentration of genetic fingerprints SARS-CoV-2 shed in wastewater infected individuals. Wastewater-based surveillance for is still its infancy. In particular, quantitative link between clinical cases observed through traditional and signals from viral concentrations developing hampers interpretation data actionable public-health decisions. We present a...